a developer of pharmaceutical products
Industry Biotechnology
A.I.dvisor indicates that over the last year, OMER has been loosely correlated with RLAY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then RLAY could also see price increases.
Ticker / NAME | Correlation To OMER | 1D Price Change % | ||
---|---|---|---|---|
OMER | 100% | -5.70% | ||
RLAY - OMER | 49% Loosely correlated | -4.71% | ||
ALDX - OMER | 49% Loosely correlated | +0.61% | ||
NTLA - OMER | 44% Loosely correlated | -3.65% | ||
VRDN - OMER | 39% Loosely correlated | -1.43% | ||
CRSP - OMER | 38% Loosely correlated | -4.61% | ||
More |
Ticker / NAME | Correlation To OMER | 1D Price Change % |
---|---|---|
OMER | 100% | -5.70% |
drugs theme (265 stocks) | 44% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 42% Loosely correlated | +5.56% |
pharmaceuticals theme (167 stocks) | 37% Loosely correlated | +0.82% |